Biopharma R&D spending for 2012 Under Seige

被引：0

|

作者：

Philippidis, Alex ^{[1
]}

机构：

[1] Genetic Engineering and Biotechnology News, United States

来源：

Genetic Engineering and Biotechnology News | 2011年 / 31卷 / 09期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[1] Biopharma R&D Spending for 2012 Under Siege
Philippidis, Alex
[J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2011, 31 (09): : 6 - +
[2] R&D spending
Lev, B
[J]. CHEMICAL & ENGINEERING NEWS, 2001, 79 (45) : 8 - 9
[3] Biopharma R&D Partnerships: From David & Goliath to Networked R&D
Ensing, Erik
[J]. R & D MANAGEMENT, 2017, 47 (02) : 330 - 331
[4] Minimizing Contamination During Biopharma R&D
Phillips, David
[J]. BIOPHARM INTERNATIONAL, 2020, 33 (07) : 40 - 42
[5] The R&D marketing interface in biopharma and medtech
Jambulingam T.
[J]. Journal of Commercial Biotechnology, 2019, 24 (04): : 116 - 123
[6] Return on R&D spending
Siemer, FH
[J]. CHEMICAL & ENGINEERING NEWS, 2001, 79 (40) : 10 - 10
[7] R&D spending on the rise
不详
[J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (08) : 566 - 566
[8] Blueprint for R&D spending
Ember, LR
Hileman, B
Lepkowski, W
Long, JR
Raber, LR
[J]. CHEMICAL & ENGINEERING NEWS, 1997, 75 (07) : 26 - 30
[9] Preserving R&D spending
Hunter, D
[J]. CHEMICAL WEEK, 2003, 165 (14) : 5 - 5
[10] US R&D spending
不详
[J]. ADVANCED MATERIALS, 1999, 11 (10) : 791 - 791

← 1 2 3 4 5 →